Article
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
18 Nov 2016
Abstract excerpt
Background: The first generation CDK2/7/9 inhibitor seliciclib (CYC202) causes multipolar anaphase and apoptosis in lung cancer cells with supernumerary centrosomes (known as anaphase catastrophe). We investigated a new and potent CDK2/9 inhibitor, CCT68127 (Cyclacel). Methods: CCT68127 was studied in lung cancer cells (three murine and five human) and control murine pulmonary epithelial and human immortalized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
